Global HIV Treatment - Turning Headwinds to Tailwinds.

Diane V Havlir, Meg C Doherty

Abstract readEditorialComment

In one paragraph

Article in The New England journal of medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

Antiretroviral Regimen and Pregnancy Outcomes of Women Living with HIV in a US Cohort.Infectious diseases in clinical practice (Baltimore, Md.) · 2023
Article
Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.The lancet. HIV · 2022
Observational
Association of intimate partner violence and other risk factors with HIV infection among married women in India: evidence from National Family Health Survey 2015-16.BMC public health · 2021
Article
Protocol for active safety monitoring of a cohort of patients using a dolutegravir-based antiretroviral regimen in Mozambique.BMJ open · 2021
Article
Weight gain during pregnancy among women initiating dolutegravir in Botswana.EClinicalMedicine · 2020
Article

4 · The record

Corrections and comments

Comment on
Dolutegravir Use at Conception - Additional Surveillance Data from Botswana.2019
Comment on
Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.2019
Comment on
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.2019
Comment on
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.2019

5 · Who and what money

Authors and funding

2 authors.

Diane V HavlirFrom the Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco (D.V.H.); and the Department of HIV/Hepatitis and Sexually Transmitted Infections, World Health Organization, Geneva (M.C.D).

Meg C DohertyFrom the Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco (D.V.H.); and the Department of HIV/Hepatitis and Sexually Transmitted Infections, World Health Organization, Geneva (M.C.D).

Funding

World Health Organization 001

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heterocyclic Compounds, 3-RingHIVBotswanaDolutegravirOxazinesPiperazinesPyridonesDolutegravirHeterocyclic Compounds, 3-RingOxazinesPiperazinesPyridones

Identifiers

PMID31339675

DOI10.1056/NEJMe1909363

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.